Bone Biologics Corp (BBLG) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 15, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Bone Biologics Corp (BBLG), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Bone Biologics Corp, the average estimate for 2027 earnings per share is −$0.59; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Bone Biologics Corp (BBLG) forecast — frequently asked questions
What are analysts forecasting for Bone Biologics Corp's earnings?
The average analyst estimate for Bone Biologics Corp (BBLG) earnings per share in 2027 is -0.59, with individual estimates between -0.59 and -0.59.
How much revenue is Bone Biologics Corp expected to make?
Analysts forecast Bone Biologics Corp (BBLG) revenue of $0 in 2027, based on 1 published estimates.
How many analysts cover BBLG?
1 analyst contribute estimates for Bone Biologics Corp (BBLG). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Devices stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.